Your only medications Supply Source
CALL US : 08048024004
We have chemotherapy and anti- cancer medications for the treatment of multiple myeloma (a type of blood cancer), cancer of the ovary, breast cancer and various types of kidney and liver cancer. The medications may be recommended along with radiotherapy in some cases for maximum benefits. There are some common side effects associated with these medicines such as dark colored urine, pale or yellowed skin, confusion, weakness, mild nausea, vomiting or diarrhea that are short term.
Erlonat (Erlotinib) belongs to the class of medicines called kinase inhibitor that contains an active ingredient erlotinib. This medicine effectively works by blocking the action of certain proteins in the body and interfering with the growth of cancer cells thereby slowing down their spread in the body.
Doctors mainly recommend this medicine to treat non-small lung cancer in patients in case, when chemotherapy medications have not been effective. If used along with other medications, it is also effective for the treatment of pancreatic cancer that has spread to other areas of the body.
A generic version of Revlimid, Lenalid (Lenalidomide) is prescribed for the treatment of a certain type of myelodysplastic syndrome caused by an abnormal chromosome. This is basically a group of conditions in which the bone marrow produces misshaped blood cells.
It is also recommended for the treatment of multiple myeloma (a type of cancer of the bone marrow) along with dexamethasone. Anemia is a condition in which the body suffers a lack of red blood cells and lenalid is a highly effective medicine for the treatment.
Sorafenat (Sorafenib) is widely recommended for patients to treat primary kidney cancer called advanced renal cell carcinoma and advanced primary liver cancer known as hepatocellular carcinoma. It contains Sorafenib as its main active ingredient that inhibits the action of the enzymes that help the cancer cells to grow and multiply. The drug also stops blood vessels from growing within the tumor, thereby preventing the cancer from spreading.
Veenat (Imatinib) is intended for the treatment in which tyrosine kinas is inhibited. The kinsases are very important proteins for the body that are responsible for regulating the growth and division of cells. It contains active ingredient Imatinib that is used for the treatment of certain tumors of the stomach and digestive system. It is a generic version of Gleevec that interferes with the growth of some cancer cells and recommended for the treatment of a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML).
We are leading exporters of Gefitinib Tablets manufactured by multinational pharma companies.
The Gefitinib Tablets are used in treatment of lung cancer as a chemotherapy medication which reduces the growth of the cancer cells in the body. Gefitinib affects the growth of cancer cells and slows their growth and spread in the body.
Gefitinib is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Gefitinib.
One 250 mg tablet of Gefitinib is recommended as a daily dose. It can be taken with or without food. Excess doses of Gefitinib will not give a better response instead it will cause increased toxicity.
We are the leading exporters of Erlotinib 100mg / 150 mg. We supply Branded & generic Erlotinib Tablets.
Erlotinib Tablet belongs to a family of cancer drugs called epidermal growth factor receptor (EGFR) inhibitors. It's a type of drug called a tyrosine kinase inhibitor. Tyrosine kinase inhibitors (TKIs) the drug available in Erlotinib stop, the growth factor receptor from activating the cancer cell. Erlotinib tablets acts on inside part of the receptor and so prevents the tyrosine kinase enzyme from being activated, which stop the cell dividing and hence stop the cancer cells from growing.
Recommended Dosage of Erlotinib is a single dose each morning with a glass of water, at least one hour before a meal or two hours afterwards.